Diagnostic and Therapy of Chronic Hepatitis B

A tétel rövid nézete
dc.contributor.advisorTornai, István
dc.contributor.advisordept2nd Internal Medicinehu_HU
dc.contributor.authorAlipour Birgani, Arsham
dc.contributor.departmentDE--Fogorvostudományi Karhu_HU
dc.contributor.opponentKovács, György
dc.contributor.opponentdeptDebreceni Egyetem::Fogorvostudományi Karhu_HU
dc.date.accessioned2018-06-06T06:27:01Z
dc.date.available2018-06-06T06:27:01Z
dc.date.created2018-03-08
dc.description.abstractIt has been approximated by the World Health Organisation that 240 million individuals are suffering from chronic hepatitis B (CHB) in the world and investigations show that majority of the affected people live in Asia and Africa by a prevalence of 75% and 12% respectively.HBV contains an envelope of lipoproteins, which has three glycoproteins on the surface of the envelope as surface antigens. The virion has two shelled and its diameter is 40-42 nm. The core or nucleocaspid of the virus is located within the envelope. There are five main phases of CHB with different patterns of liver histology, DNA amount, ALT level, HBeAg status and thus different reactions to antiviral therapy in each phase. CHB virus infection might be with no symptoms or it can lead to a long term inflammation of hepatic tissue or chronic hepatitis which can cause cirrhosis after years. In this case the chance for developing the hepatocellular carcinoma (HCC) is increasedhu_HU
dc.description.correctorgj
dc.description.coursefogorvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent34hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/254911
dc.language.isoenhu_HU
dc.subjectDiagnosticshu_HU
dc.subjecttherapy
dc.subjectinfection control
dc.subjectChronic Hepatitis B
dc.subject.dspaceDEENK Témalista::Orvostudomány::Fogorvostudományhu_HU
dc.titleDiagnostic and Therapy of Chronic Hepatitis Bhu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Dentistry)